Pacific Hospital Supply Co., Ltd (TPEX:4126)
Taiwan
· Delayed Price · Currency is TWD 80.30
-1.40 (-1.71%)
Mar 9, 2026, 1:30 PM CST
Pacific Hospital Supply Revenue
In the year 2025, Pacific Hospital Supply had annual revenue of 2.41B TWD with 2.59% growth. Pacific Hospital Supply had revenue of 576.49M in the quarter ending December 31, 2025, a decrease of -9.83%.
Revenue
2.41B
Revenue Growth
+2.59%
P/S Ratio
2.42
Revenue / Employee
2.98M
Employees
807
Market Cap
5.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.41B | 60.65M | 2.59% |
| Dec 31, 2024 | 2.35B | 25.05M | 1.08% |
| Dec 31, 2023 | 2.32B | 135.28M | 6.19% |
| Dec 31, 2022 | 2.18B | 166.19M | 8.23% |
| Dec 31, 2021 | 2.02B | -153.07M | -7.05% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Formosa Optical Technology | 3.98B |
| St.Shine Optical | 4.40B |
| SciVision Biotech | 890.43M |
| Medeon Biodesign | 381.90M |
| Bioteque | 2.07B |
| Bionime | 1.91B |
| Nang Kuang Pharmaceutical | 2.16B |
| Maxigen Biotech | 792.49M |